Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2013; 19(29): 4702-4717
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4702
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4702
Figure 1 Morphological features, immunophenotypic characterization and differentiation assays of compact bone-derived mouse mesenchymal stem cells.
A: At 72 h after initial culture, the cells migrate out from the enzyme-digested bone chips (× 100); B: Green fluorescent protein -bone marrow mesenchymal stem cells (BMSCs) arranged in a bunched or radiated shape without weakening of the green fluorescence after passages (× 400); C: Osteoplastic differentiation of BMSCs (× 400); D: Apoplastic differentiation of BMSCs (× 400); E-H: BMSCs’ phenotypes detected by flow cytometry.
- Citation: Chen QQ, Yan L, Wang CZ, Wang WH, Shi H, Su BB, Zeng QH, Du HT, Wan J. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses. World J Gastroenterol 2013; 19(29): 4702-4717
- URL: https://www.wjgnet.com/1007-9327/full/v19/i29/4702.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i29.4702